Alcon AG (ALC)vsFemasys Inc (FEMY)
ALC
Alcon AG
$66.81
+0.35%
HEALTHCARE · Cap: $33.11B
FEMY
Femasys Inc
$0.37
-1.75%
HEALTHCARE · Cap: $925,180
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 463599% more annual revenue ($10.63B vs $2.29M). ALC leads profitability with a 7.7% profit margin vs 0.0%. ALC earns a higher WallStSmart Score of 49/100 (D+).
ALC
Hold49
out of 100
Grade: D+
FEMY
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-24.0%
Fair Value
$64.04
Current Price
$66.81
$2.77 premium
Intrinsic value data unavailable for FEMY.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 39.9% year-over-year
Areas to Watch
Expensive relative to growth rate
ROE of 3.7% — below average capital efficiency
7.7% margin — thin
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Price/Book, Debt/Equity.
Bull Case : FEMY
The strongest argument for FEMY centers on Revenue Growth. Revenue growth of 39.9% demonstrates continued momentum.
Bear Case : ALC
The primary concerns for ALC are PEG Ratio, Return on Equity, Profit Margin. A P/E of 40.7x leaves little room for execution misses.
Bear Case : FEMY
The primary concerns for FEMY are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
ALC profiles as a value stock while FEMY is a hypergrowth play — different risk/reward profiles.
ALC carries more volatility with a beta of 0.70 — expect wider price swings.
FEMY is growing revenue faster at 39.9% — sustainability is the question.
ALC generates stronger free cash flow (274M), providing more financial flexibility.
Bottom Line
ALC scores higher overall (49/100 vs 38/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →Femasys Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Femasys Inc. is an innovative medical technology company dedicated to transforming women's healthcare through its proprietary solutions for diagnosing and treating gynecological conditions. With a focus on non-surgical alternatives, Femasys is addressing prevalent issues such as uterine fibroids and contraception, positioning itself as a key player in the growing field of women’s health. As demand for minimally invasive treatments continues to rise, the company is strategically equipped to enhance patient outcomes and efficiency in healthcare delivery. By concentrating on significant unmet needs, Femasys aims to set new standards for care in this essential sector.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?